Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Challenges in the development of vaccines against COVID-19].
Ontiveros-Padilla LA, Rivera-Hernández T, López-Macías C. Ontiveros-Padilla LA, et al. Rev Med Inst Mex Seguro Soc. 2020 Sep 21;58(Supl 2):S116-118. doi: 10.24875/RMIMSS.M20000122. Rev Med Inst Mex Seguro Soc. 2020. PMID: 34695323 Spanish.
[The role of T Cells in SARS-CoV-2 Infection].
Bonifaz LC, Ontiveros-Padilla LA, López-Macías C. Bonifaz LC, et al. Rev Med Inst Mex Seguro Soc. 2020 Sep 21;58(Supl 2):S312-315. doi: 10.24875/RMIMSS.M20000144. Rev Med Inst Mex Seguro Soc. 2020. PMID: 34695345 Spanish.
Microparticle and nanoparticle-based influenza vaccines.
Ontiveros-Padilla L, Bachelder EM, Ainslie KM. Ontiveros-Padilla L, et al. J Control Release. 2024 Nov 5;376:880-898. doi: 10.1016/j.jconrel.2024.10.031. Online ahead of print. J Control Release. 2024. PMID: 39427775 Review.
Newcastle disease virus vector-based SARS-CoV-2 vaccine candidate AVX/COVID-12 activates T cells and is recognized by antibodies from COVID-19 patients and vaccinated individuals.
Torres-Flores A, Ontiveros-Padilla LA, Madera-Sandoval RL, Tepale-Segura A, Gajón-Martínez J, Rivera-Hernández T, Ferat-Osorio EA, Cérbulo-Vázquez A, Arriaga-Pizano LA, Bonifaz L, Paz-De la Rosa G, Rojas-Martínez O, Suárez-Martínez A, Peralta-Sánchez G, Sarfati-Mizrahi D, Sun W, Chagoya-Cortés HE, Palese P, Krammer F, García-Sastre A, Lozano-Dubernard B, López-Macías C. Torres-Flores A, et al. Among authors: ontiveros padilla la. Front Immunol. 2024 May 30;15:1394114. doi: 10.3389/fimmu.2024.1394114. eCollection 2024. Front Immunol. 2024. PMID: 38873610 Free PMC article.
Immunogenicity of an adjuvanted broadly active influenza vaccine in immunocompromised and diverse populations.
Hendy DA, Pena ES, Ontiveros-Padilla L, Dixon TA, Middleton DD, Williamson GL, Lukesh NR, Simpson SR, Stiepel RT, Islam MJ, Carlock MA, Ross TM, Bachelder EM, Ainslie KM. Hendy DA, et al. Among authors: ontiveros padilla l. Bioeng Transl Med. 2023 Dec 8;9(2):e10634. doi: 10.1002/btm2.10634. eCollection 2024 Mar. Bioeng Transl Med. 2023. PMID: 38435811 Free PMC article.
In vivo evaluation of new adjuvant systems based on combination of Salmonella Typhi porins with particulate systems: Liposomes versus polymeric particles.
Parmaksız S, Pekcan M, Özkul A, Türkmen E, Rivero-Arredondo V, Ontiveros-Padilla L, Forbes N, Perrie Y, López-Macías C, Şenel S. Parmaksız S, et al. Among authors: ontiveros padilla l. Int J Pharm. 2023 Dec 15;648:123568. doi: 10.1016/j.ijpharm.2023.123568. Epub 2023 Nov 2. Int J Pharm. 2023. PMID: 37925042
12 results